
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki
Unlock the market timeline & signal feed
226 signals in the last 90 days.
The order this company entered each market — oldest to newest
99 active postings
Process Expert (m/f/d)
Sign up to see the full signal feed
How Novartis's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
NovartisYou | 48 | 3 | +3% | 201 | 53 |
Lifecycle Management Manager
View postingMoscow Metropolitan Area · Full-time · yesterday
Expert Drug Supply
View postingBasel, Switzerland · last wk.
Medical Science Liaison -IMMU
View postingChangsha, Hunan, China · Full-time · yesterday
Proud partner. Real inclusion. Real impact.
EndedWelcome to where we thrive together
EndedNovartis Careers
EndedAI sleep healthcare company HoneyNaps opens new office in Boston's Kendall Square through Korea's Bio-health Global Expansion Program to accelerate U.S. partnerships and commercialization.
ACROBiosystems presented AI-driven protein solutions at AACR 2026, featuring its Acro-AIx system with DeepExp and ProDeSol models for protein design optimization and therapeutic development.
EU launches pilot program for innovative medical devices and diagnostics in Q2, addressing regulatory modernization. Global healthcare trends include AI integration, trade policy impacts, and medical tourism expansion.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Novartis's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.